Advertisement
Screener

Infinity Pharmaceuticals, Inc. Form SC 13D: Beneficial ownership report (active)

Infinity Pharmaceuticals, Inc. Form SC 13D: Beneficial ownership report (active)

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-02-16: Form SC 13D/A; Description AMENDMENT NO. 6 TO THE SCHEDULE 13D; Document sc13da607422infi_02162021.htm.
  • 2021-01-26: Form SC 13D/A; Description AMENDMENT NO. 5 TO THE SCHEDULE 13D; Document sc13da507422infi_01262021.htm.
  • 2020-11-12: Form SC 13D/A; Description AMENDMENT NO. 4 TO SCHEDULE 13D; Document sc13da407422infi_11122020.htm.
  • 2020-01-10: Form SC 13D/A; Description AMENDMENT NO. 3 TO THE SCHEDULE 13D; Document sc13da307422inf_01102020.htm.
FiledFormPeriod of reportDescriptionDocument
2021-02-16SC 13D/AAMENDMENT NO. 6 TO THE SCHEDULE 13Dsc13da607422infi_02162021.htm
2021-01-26SC 13D/AAMENDMENT NO. 5 TO THE SCHEDULE 13Dsc13da507422infi_01262021.htm
2020-11-12SC 13D/AAMENDMENT NO. 4 TO SCHEDULE 13Dsc13da407422infi_11122020.htm
2020-01-10SC 13D/AAMENDMENT NO. 3 TO THE SCHEDULE 13Dsc13da307422inf_01102020.htm
2018-11-21SC 13D/AAMENDMENT NO. 2 TO THE SCHEDULE 13Dsc13da207422027_11212018.htm
2018-06-21SC 13D/AAMENDMENT NO. 1 TO THE SCHEDULE 13Dsc13da107422027_06212018.htm
2018-04-12SC 13DTHE SCHEDULE 13Dsc13d07422027_04122018.htm
2013-04-16SC 13D/ASC 13D/Ad522096dsc13da.htm
2013-04-12SC 13D/ASC 13D/Ad520841dsc13da.htm
2012-09-17SC 13D/AAMENDMENT NO. 4 TO SCHEDULE 13Dinfinity13da09172012.htm
2012-07-19SC 13D/AAMENDMENT NO. 3 TO SCHEDULE 13Dinfinity13da07192012.htm
2012-07-02SC 13D/ASCHEDULE 13D AMENDMENT NO. 2infinity13da07022012.htm
2009-01-16SC 13D/ASCHEDULE 13D/Ac79416sc13dza.htm
2008-12-01SC 13DSC 13Dc77867sc13d.htm
2004-05-19SC 13D/AGENERAL STATEMENT OF BENEFICIAL OWNERSHIPb332144_sch13d.txt
2003-02-13SC 13DINFORMATION TO BE INCLUDED IN STATEMENTS FILEDb322996_13d.txt